Our Approach to ESG

Inogen’s purpose of improving lives through respiratory care is supported by our vision to be a global market leader with innovative, evidence-based chronic respiratory care solutions.

We have compiled this summary report of our ESG activities and results as evidence of our commitment to what we believe is important to our customers, patients, employees, suppliers, and investors. 

Our ESG strategy is grounded in business sustainability, our Core Values, and our Code of Ethics and Conduct. We are committed to diversity, equity, and inclusion in hiring and developing our talent, which we believe is critical to our future growth and success. 

Inogen was founded in 2001 to help patients who require long-term oxygen therapy live their lives to the fullest without having limited mobility as a result of using other oxygen delivery modalities. Our compact, lightweight, and travel-approved portable oxygen concentrators are designed to help patients improve ambulation and regain some of their mobility while meeting their oxygen therapy needs. Past studies have shown that mobility combined with compliant oxygen therapy reduces hospital stays and extends the life of patients with chronic respiratory conditions, which contributes to better health outcomes. 

We are proud of the cumulative impact we have had on the patients using the over one million systems we have sold or rented worldwide since our inception.

We are committed to research and development to stay at the forefront of respiratory therapy treatments and to driving the penetration of portable oxygen concentrators for the benefit of the largest possible patient population worldwide.  

We look forward to continuing to expand our ESG program while also helping thousands of patients every year.